Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Mark W. Sleeman0
Stanley J. Wiegand0
Date of Patent
May 30, 2006
0Patent Application Number
108111700
Date Filed
March 26, 2004
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Methods of treating diabetes in mammals, particularly humans, by blocking or inhibiting VEGF-mediated activity. A preferred inhibitor of VEGF-mediated activity is a VEGF antagonist such as a VEGF trap capable of binding and blocking VEGF.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
